<DOC>
	<DOCNO>NCT02101151</DOCNO>
	<brief_summary>The incidence type 2 diabetes mellitus obesity increase alarm rate nationally worldwide . Accumulating evidence suggest serum cholecalciferol level may inversely related prevalence diabetes , insulin resistance metabolic syndrome . However , demonstrate causal relation vitamin D glucose metabolism , evidence randomize adequately power placebo-controlled intervention trial needed.The trial available effect Vitamin D supplementation conclusive . Hence , purpose study conduct double-blind randomized trial Vitamin D deficient obese type 2 diabetic Emirati population clarify effect vitamin D supplementation glycemic control obesity parameter .</brief_summary>
	<brief_title>Effect Vitamin D Supplementation Metabolic Control Body Composition Type 2 Diabetes Subjects Ajman ( UAE )</brief_title>
	<detailed_description>Vitamin D insufficiency report risk factor development type 1 type 2 diabetes mellitus . In contrast finding observational study , supplementation trial type 2 diabetes mellitus ( T2DM ) report definitive conclusion , suggest supplementation early stage development diabetes may benefit delay progression clinical T2DM increase pancreatic insulin release improve insulin resistance plus impaired glucose tolerance.There also speculation role vitamin D physiology weight loss body composition.However , multiple inconsistency within report trial i.e . sample size , dose vitamin D , frequency supplementation , population study . Hence randomise clinical trial undertaken study effect vitamin D ( Cholecalciferol ) supplementation metabolic marker obesity parameter vitamin D deficient obese type 2 diabetic subject .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Avitaminosis</mesh_term>
	<mesh_term>Rickets</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>United Arab Emirates national Male Female Age 3065 year Diagnosed type 2 diabetes Body Mass Index ≥30 kg/m2 Serum 25 hydroxy Vitamin D ≤ 50nmol/L Type 1 diabetes mellitus History evidence liver failure ( elevate liver function test ) renal failure ( elevated creatinine ) History malabsorption syndrome . On vitamin D Supplementation On hormone replacement therapy On corticosteroid , anticonvulsant , AIDS medication</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>vitamin D</keyword>
	<keyword>cholecalciferol</keyword>
	<keyword>obesity</keyword>
</DOC>